An Intestinal Epithelial Defect Conferring ER Stress Results in Inflammation Involving Both Innate and Adaptive Immunity

Overview

Journal Mucosal Immunol

Publisher Elsevier

Specialty Allergy & Immunology

Date 2010 Nov 26

PMID 21107311

Citations 64

Authors

R D Eri

R J Adams

T V Tran

H Tong

I Das

D K Roche

I Oancea

C W Png

P L Jeffery

G L Radford-Smith

M C Cook

T H Florin

M A McGuckin

Affiliations

Soon will be listed here.

Abstract

We recently characterized Winnie mice carrying a missense mutation in Muc2, leading to severe endoplasmic reticulum stress in intestinal goblet cells and spontaneous colitis. In this study, we characterized the immune responses due to this intestinal epithelial dysfunction. In Winnie, there was a fourfold increase in activated dendritic cells (DCs; CD11c(+) major histocompatibility complex (MHC) class II(hi)) in the colonic lamina propria accompanied by decreased colonic secretion of an inhibitor of DC activation, thymic stromal lymphopoietin (TSLP). Winnie also displayed a significant increase in mRNA expression of the mucosal T(H)17 signature genes Il17a, IL17f, Tgfb, and Ccr6, particularly in the distal colon. Winnie mesenteric lymph node leukocytes secreted multiple T(H)1, T(H)2, and T(H)17 cytokines on activation, with a large increase in interleukin-17A (IL-17A) progressively with age. A major source of mucosal IL-17A in Winnie was CD4(+) T lymphocytes. Loss of T and B lymphocytes in Rag1(-/-) × Winnie (RaW) crosses did not prevent spontaneous inflammation but did prevent progression with age in the colon but not the cecum. Adoptive transfer of naive T cells into RaW mice caused more rapid and severe colitis than in Rag1(-/-), indicating that the epithelial defect results in an intestinal microenvironment conducive to T-cell activation. Thus, the Winnie primary epithelial defect results in complex multicytokine-mediated colitis involving both innate and adaptive immune components with a prominent IL-23/T(H)17 response, similar to that of human ulcerative colitis.

Citing Articles

Early life factors, diet and microbiome, and risk of inflammatory bowel disease.

Mak J, Lo A, Ng S J Can Assoc Gastroenterol. 2025; 8(Suppl 2):S44-S50.

PMID: 39990509 PMC: 11842909. DOI: 10.1093/jcag/gwae039.

Successful Manipulation of the Gut Microbiome to Treat Spontaneous and Induced Murine Models of Colitis.

Movva R, Murtaza N, Giri R, Png C, Davies J, Alabbas S Gastro Hep Adv. 2024; 1(3):359-374.

PMID: 39131681 PMC: 11307790. DOI: 10.1016/j.gastha.2021.12.008.

Alterations in tryptophan metabolism and NAD biosynthesis within the microbiota-gut-brain axis in chronic intestinal inflammation.

Devereaux J, Robinson A, Stavely R, Davidson M, Dargahi N, Ephraim R Front Med (Lausanne). 2024; 11:1379335.

PMID: 39015786 PMC: 11250461. DOI: 10.3389/fmed.2024.1379335.

The IRE1α/XBP1 pathway sustains cytokine responses of group 3 innate lymphoid cells in inflammatory bowel disease.

Cao S, Fachi J, Ma K, Ulezko Antonova A, Wang Q, Cai Z J Clin Invest. 2024; 134(13).

PMID: 38722686 PMC: 11214543. DOI: 10.1172/JCI174198.

Bone marrow-derived mesenchymal stem cells mitigate chronic colitis and enteric neuropathy via anti-inflammatory and anti-oxidative mechanisms.

Stavely R, Robinson A, Fraser S, Filippone R, Stojanovska V, Eri R Sci Rep. 2024; 14(1):6649.

PMID: 38503815 PMC: 10951223. DOI: 10.1038/s41598-024-57070-6.

References

OConnor Jr W, Kamanaka M, Booth C, Town T, Nakae S, Iwakura Y . A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol. 2009; 10(6):603-9. PMC: 2709990. DOI: 10.1038/ni.1736. View

Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y . Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol. 2004; 110(1):55-62. DOI: 10.1016/j.clim.2003.09.013. View

Cadwell K, Liu J, Brown S, Miyoshi H, Loh J, Lennerz J . A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008; 456(7219):259-63. PMC: 2695978. DOI: 10.1038/nature07416. View

Olson A, Ayass M, Chensue S . Tumor necrosis factor and IL-1 beta expression in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1993; 16(3):241-6. DOI: 10.1097/00005176-199304000-00003. View

Fuss I, Neurath M, Boirivant M, Klein J, de La Motte C, Strong S . Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol. 1996; 157(3):1261-70. View

Ito R, Kita M, Shin-Ya M, Kishida T, Urano A, Takada R . Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun. 2008; 377(1):12-6. DOI: 10.1016/j.bbrc.2008.09.019. View

Elson C, Cong Y, Weaver C, Schoeb T, McClanahan T, Fick R . Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology. 2007; 132(7):2359-70. DOI: 10.1053/j.gastro.2007.03.104. View

Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B . Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 2005; 129(2):550-64. DOI: 10.1016/j.gastro.2005.05.002. View

OConnor Jr W, Zenewicz L, Flavell R . The dual nature of T(H)17 cells: shifting the focus to function. Nat Immunol. 2010; 11(6):471-6. DOI: 10.1038/ni.1882. View

10.

Izcue A, Coombes J, Powrie F . Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol. 2009; 27:313-38. DOI: 10.1146/annurev.immunol.021908.132657. View

11.

Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y . Increased expression of interleukin 17 in inflammatory bowel disease. Gut. 2002; 52(1):65-70. PMC: 1773503. DOI: 10.1136/gut.52.1.65. View

12.

Kadivar K, Ruchelli E, Markowitz J, DeFelice M, Strogatz M, Kanzaria M . Intestinal interleukin-13 in pediatric inflammatory bowel disease patients. Inflamm Bowel Dis. 2004; 10(5):593-8. DOI: 10.1097/00054725-200409000-00014. View

13.

van der Sluis M, de Koning B, de Bruijn A, Velcich A, Meijerink J, van Goudoever J . Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology. 2006; 131(1):117-29. DOI: 10.1053/j.gastro.2006.04.020. View

14.

Mahida Y, Wu K, Jewell D . Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut. 1989; 30(6):835-8. PMC: 1434123. DOI: 10.1136/gut.30.6.835. View

15.

Weigmann B, Tubbe I, Seidel D, Nicolaev A, Becker C, Neurath M . Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc. 2007; 2(10):2307-11. DOI: 10.1038/nprot.2007.315. View

16.

Brandl K, Rutschmann S, Li X, Du X, Xiao N, Schnabl B . Enhanced sensitivity to DSS colitis caused by a hypomorphic Mbtps1 mutation disrupting the ATF6-driven unfolded protein response. Proc Natl Acad Sci U S A. 2009; 106(9):3300-5. PMC: 2651297. DOI: 10.1073/pnas.0813036106. View

17.

Yu Q, Saruta M, Avanesyan A, Fleshner P, Banham A, Papadakis K . Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm Bowel Dis. 2007; 13(2):191-9. DOI: 10.1002/ibd.20053. View

18.

Reimund J, Wittersheim C, Dumont S, Muller C, Baumann R, Poindron P . Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease. J Clin Immunol. 1996; 16(3):144-50. DOI: 10.1007/BF01540912. View

19.

Uhlig H, McKenzie B, Hue S, Thompson C, Joyce-Shaikh B, Stepankova R . Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity. 2006; 25(2):309-18. DOI: 10.1016/j.immuni.2006.05.017. View

20.

Yen D, Cheung J, Scheerens H, Poulet F, Mcclanahan T, McKenzie B . IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest. 2006; 116(5):1310-6. PMC: 1451201. DOI: 10.1172/JCI21404. View